CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI Initiative Recognized as Key Growth Driver
CareCloud (NASDAQ: CCLD) has been named the "Top Healthcare IT Pick for 2025" by Maxim Group, highlighting the company's AI strategy and strong financial performance. Maxim Group's analyst Allen Klee emphasized CareCloud's attractive valuation, noting it trades at a 2026 EV/EBITDA multiple of 5.0x, significantly below the peer group average of 12.5x.
The company reported impressive Q1 2025 results with 52% year-over-year adjusted EBITDA growth. CareCloud's recently launched AI Center of Excellence, starting with 50 AI professionals and planning to expand to 500 by year-end, demonstrates its commitment to AI integration. The company's AI suite includes tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, positioning CareCloud as a leader in healthcare AI solutions.
CareCloud (NASDAQ: CCLD) è stata nominata "Top Healthcare IT Pick per il 2025" da Maxim Group, che ha evidenziato la strategia AI dell'azienda e la sua solida performance finanziaria. L'analista di Maxim Group, Allen Klee, ha sottolineato la valutazione interessante di CareCloud, osservando che è scambiata a un multiplo EV/EBITDA 2026 di 5,0x, molto inferiore alla media del gruppo di pari, pari a 12,5x.
L'azienda ha riportato risultati impressionanti nel primo trimestre 2025 con una crescita dell'EBITDA rettificato del 52% su base annua. Il recentemente lanciato AI Center of Excellence di CareCloud, che parte con 50 professionisti AI e prevede di espandersi a 500 entro la fine dell'anno, dimostra il suo impegno nell'integrazione dell'intelligenza artificiale. La suite AI dell'azienda include strumenti come cirrusAI Notes, cirrusAI Appeals e cirrusAI Voice, posizionando CareCloud come leader nelle soluzioni AI per la sanità.
CareCloud (NASDAQ: CCLD) ha sido nombrada "Mejor opción en TI para el sector salud en 2025" por Maxim Group, destacando la estrategia de IA de la compañía y su sólido desempeño financiero. El analista de Maxim Group, Allen Klee, enfatizó la valoración atractiva de CareCloud, señalando que cotiza a un múltiplo EV/EBITDA 2026 de 5.0x, muy por debajo del promedio del grupo de pares de 12.5x.
La empresa reportó resultados impresionantes en el primer trimestre de 2025 con un crecimiento interanual del EBITDA ajustado del 52%. El recientemente lanzado Centro de Excelencia en IA de CareCloud, que comenzó con 50 profesionales en IA y planea expandirse a 500 para fin de año, demuestra su compromiso con la integración de la inteligencia artificial. La suite de IA de la compañía incluye herramientas como cirrusAI Notes, cirrusAI Appeals y cirrusAI Voice, posicionando a CareCloud como líder en soluciones de IA para la salud.
CareCloud (NASDAQ: CCLD)가 Maxim Group으로부터 "2025년 최고의 헬스케어 IT 선정"을 받으며 회사의 AI 전략과 강력한 재무 성과가 주목받았습니다. Maxim Group의 애널리스트 Allen Klee는 CareCloud의 매력적인 밸류에이션을 강조하며, 동종업계 평균 12.5배에 비해 2026년 EV/EBITDA 배수 5.0배로 거래되고 있다고 밝혔습니다.
회사는 2025년 1분기 조정 EBITDA가 전년 대비 52% 성장하는 인상적인 실적을 보고했습니다. 최근 출범한 AI 센터 오브 엑설런스는 50명의 AI 전문가로 시작해 연말까지 500명으로 확장할 계획이며, 이는 AI 통합에 대한 회사의 강한 의지를 보여줍니다. CareCloud의 AI 제품군에는 cirrusAI Notes, cirrusAI Appeals, cirrusAI Voice 등이 포함되어 있어 헬스케어 AI 솔루션 분야의 선두주자로 자리매김하고 있습니다.
CareCloud (NASDAQ : CCLD) a été désignée « Meilleur choix IT santé pour 2025 » par Maxim Group, mettant en avant la stratégie d’IA de l’entreprise ainsi que ses solides performances financières. L’analyste Allen Klee de Maxim Group a souligné la valorisation attractive de CareCloud, notant que l’action se négocie à un multiple EV/EBITDA 2026 de 5,0x, bien en dessous de la moyenne du groupe de pairs, qui est de 12,5x.
L’entreprise a publié des résultats impressionnants pour le premier trimestre 2025 avec une croissance de 52 % de l’EBITDA ajusté en glissement annuel. Le Centre d’Excellence IA récemment lancé par CareCloud, démarrant avec 50 professionnels de l’IA et prévoyant d’atteindre 500 d’ici la fin de l’année, témoigne de son engagement envers l’intégration de l’intelligence artificielle. La suite d’outils IA de l’entreprise inclut cirrusAI Notes, cirrusAI Appeals et cirrusAI Voice, positionnant CareCloud comme un leader des solutions d’IA dans le secteur de la santé.
CareCloud (NASDAQ: CCLD) wurde von der Maxim Group als "Top Healthcare IT Pick für 2025" ausgezeichnet, wobei die KI-Strategie des Unternehmens und die starke finanzielle Leistung hervorgehoben wurden. Der Analyst der Maxim Group, Allen Klee, betonte die attraktive Bewertung von CareCloud und stellte fest, dass das Unternehmen mit einem 2026er EV/EBITDA-Multiplikator von 5,0x gehandelt wird, was deutlich unter dem Durchschnitt der Peer-Gruppe von 12,5x liegt.
Das Unternehmen meldete beeindruckende Ergebnisse für das erste Quartal 2025 mit einem bereinigten EBITDA-Wachstum von 52 % im Jahresvergleich. Das kürzlich gestartete AI Center of Excellence von CareCloud, das mit 50 KI-Experten begann und plant, bis Jahresende auf 500 zu expandieren, zeigt das Engagement für die Integration von KI. Die KI-Suite des Unternehmens umfasst Tools wie cirrusAI Notes, cirrusAI Appeals und cirrusAI Voice und positioniert CareCloud als führenden Anbieter von KI-Lösungen im Gesundheitswesen.
- 52% year-over-year adjusted EBITDA growth in Q1 2025
- Attractive valuation at 5.0x EV/EBITDA, significantly below peer average of 12.5x
- Resumption of preferred dividends indicating financial strength
- Strong positive free cash flow generation
- Expansion of AI Center of Excellence from 50 to 500 professionals by year-end
- Return to M&A-driven growth strategy
- None.
SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions, today announced that Maxim Group, LLC (“Maxim Group”), a leading investment bank, securities and wealth management firm, has selected CareCloud as its “Top Healthcare IT Pick for 2025,” citing the transformative potential of its artificial intelligence strategy, together with its strong financial results and renewed M&A activity.
“Given its positive outlook and attractive valuation, CareCloud is positioned to be our top healthcare IT pick in 2025,” said Allen Klee, CFA, Managing Director and Senior Equity Research Analyst at Maxim Group, in a research report released May 7, 2025. In the same report, Klee noted that CareCloud trades at a 2026 EV/EBITDA multiple of 5.0x, which indicates a significant discount compared to the identified peer group average of 12.5x—an opportunity he believes enhances the Company’s investment appeal.
“We are honored to be named Maxim’s ‘Top Healthcare IT Pick for 2025,’” said Stephen Snyder, Co-CEO of CareCloud. “This endorsement underscores the power of our disciplined strategy and our commitment to transforming healthcare operations through scalable, purpose-built AI.”
Maxim’s report highlights several factors contributing to CareCloud’s momentum, including the launch of its AI Center of Excellence, strong positive free cash flow, resumption of preferred dividends, and a return to M&A-driven growth. The firm also emphasized CareCloud’s AI suite—featuring tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice—as a core differentiator.
The recognition follows CareCloud’s strong Q1 2025 performance, including
“AI is now deeply integrated into our operations—from documentation and revenue cycle management to patient engagement and analytics,” said Hadi Chaudhry, Co-CEO of CareCloud. “This is not an add-on, it is a foundational capability that is changing how healthcare is delivered and experienced.”
As CareCloud continues to execute on its growth strategy, the Company remains committed to delivering enterprise-grade, cost-effective technology that helps healthcare organizations achieve better outcomes, higher efficiency, and sustained financial performance.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. To learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
About Maxim Group
Maxim Group is a leading full-service investment bank, securities, and wealth management firm headquartered in Midtown Manhattan. Founded in 2002, Maxim Group offers a comprehensive suite of financial services, including investment banking, equity research, wealth management, and brokerage services. The firm is a registered broker-dealer with the SEC, FINRA, and SIPC, and is known for its deep expertise across multiple sectors, including healthcare, technology, and energy. Maxim Group employs over 200 professionals and maintains a strong presence in the financial services industry. For more information, visit https://www.maximgrp.com/about.
Disclaimer
This press release is for information purposes only and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Maxim Group’s designation of CareCloud as a Top Healthcare IT pick reflects the independent opinion of its equity research analyst as of the date of the published report. CareCloud does not provide compensation for Maxim Group’s analyst coverage, and no endorsement is implied. Maxim Group’s opinions, analyses, conclusions, and the facts upon which it relied in developing the same, are its own independent work product and CareCloud neither endorses nor adopts the same.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ
What is CareCloud's (CCLD) current valuation compared to its peers?
How much did CareCloud's (CCLD) EBITDA grow in Q1 2025?
What is CareCloud's (CCLD) AI strategy for 2025?
Why did Maxim Group choose CareCloud (CCLD) as top healthcare IT pick for 2025?
Has CareCloud (CCLD) resumed dividend payments?
